Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Shin Nippon Biomedical Laboratories
AddedFeb 15, 2024
UpdatedJun 28, 2026
Shin Nippon Biomedical Laboratories

Shin Nippon Biomedical Laboratories

Public

Tokyo-based SNBL, a pioneering contract research organization, offers global pharmaceutical research and development services, with over 50 years of experience.

HQ
Tokyo, Tokyo, JP
Founded
1957
Overview
Compare
Employees
Website

Founded in 1957 in Kagoshima, Shin Nippon Biomedical Laboratories (SNBL) is Japan’s first contract research organization (CRO). The company has grown into a global leader in pharmaceutical research and development, offering services in pre-clinical research, clinical pharmacology, pharmacokinetics, clinical trials, and site management organization (SMO). SNBL aims to advance healthcare by providing comprehensive and innovative research solutions, focusing on improving drug development efficiency and safety.

SNBL has established strong partnerships and collaborations within the pharmaceutical industry, leveraging its extensive experience and expertise. Notable achievements include significant contributions to translational research and the development of new therapeutic methodologies. The company's impact is evident in its role in accelerating drug discovery and development processes, thereby enhancing the overall quality of healthcare globally.

Shin Nippon Biomedical Laboratories - Similar Companies

Snbl USA logo

Snbl USA

Shionogi & Co. logo

Shionogi & Co.

ONO Pharmaceutical logo

ONO Pharmaceutical

Novartis logo

Novartis

novartis.com

Novartis Institutes For Biomedical Research logo

Novartis Institutes For Biomedical Research

novartis.com

Syneos Health logo

Syneos Health

syneoshealth.com

NJ Bio logo

NJ Bio

njbio.com

Tigermed logo

Tigermed

Quintiles logo

Quintiles

quintiles.com

Kyntra Bio logo

Kyntra Bio

fibrogen.com

Albany Molecular Research Inc. - Amri logo

Albany Molecular Research Inc. - Amri

amriglobal.com

Zai Lab logo

Zai Lab

zailaboratory.com

Astellas Pharma logo

Astellas Pharma

KBI Biopharma logo

KBI Biopharma

Societal Cdmo logo

Societal Cdmo

societalcdmo.com

Shin Nippon Biomedical Laboratories - Quick Facts

Who are Shin Nippon Biomedical Laboratories' competitors?

Companies similar to Shin Nippon Biomedical Laboratories include Snbl USA, Shionogi & Co., ONO Pharmaceutical and Novartis.

When was Shin Nippon Biomedical Laboratories founded?

Shin Nippon Biomedical Laboratories was founded in 1957.

Where is Shin Nippon Biomedical Laboratories' headquarters located?

Shin Nippon Biomedical Laboratories' headquarters is located in Tokyo, Tokyo, JP.

How many employees does Shin Nippon Biomedical Laboratories have?

Shin Nippon Biomedical Laboratories has 750 employees as of Feb 4, 2024.

Shin Nippon Biomedical Laboratories - Classification

Industry
  • Professional Service Companies
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Customer
  • Enterprise
Main Product
  • Pharmaceutical Research
Tags
  • Consulting
  • CRO
  • Pharma
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 621000Ambulatory Health Care Services
  • 621500Medical and Diagnostic Laboratories
  • 621510Medical and Diagnostic Laboratories
  • 621511Medical Laboratories
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 8070Medical And Dental Laboratories
  • 8071Medical Laboratories
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified